333 Bay St, Suite 2400, Bay Adelaide Ctr, Box 20, Toronto, ON
Year called to bar: 2000 (ON)
Ingrid VanderElst is Co-Chair of the Ontario region’s Life Sciences group. Regularly assisting clients in the health products and related service industries, Ingrid advises on regulatory and intellectual property issues. Clients include pharmaceutical, natural health product, medical device, cosmetic and food manufacturers, as well as pharmacy and laboratory services providers and agri-business operators. On the regulatory side, Ingrid has assisted clients with product licensing, establishment licensing, manufacturing requirements (including GMP compliance), packaging and labeling reviews, as well as advised on advertising, marketing and distribution, product recalls, drug pricing (including PMPRB compliance) and reimbursement issues, including formulary listing. As regards intellectual property matters, she advises on licensing and transfer of patents and trademarks, patent and trademark prosecution, patent listing under the Patented Medicines (Notice of Compliance) Regulations and data protection, and provides support on the acquisition or disposition of technology assets and intellectual property portfolios.
On July 30, 2018, BWX Technologies, Inc. (NYSE:BWXT) (BWXT), a leading supplier of nuclear components and services, completed the acquisition of the medical isotope business of Nordion (Canada) Inc. (Nordion) from private-equity owned Sotera Health LLC (Sotera Health).